NovoLog (Dispensing Solutions, Inc.)
Welcome to the PulseAid listing for the NovoLog drug offered from Dispensing Solutions, Inc.. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dispensing Solutions, Inc. |
NON-PROPRIETARY NAME: | insulin aspart |
SUBSTANCE NAME: | INSULIN ASPART |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-01-22 |
END MARKETING DATE: | 0000-00-00 |
NovoLog HUMAN PRESCRIPTION DRUG Details:
Item Description | NovoLog from Dispensing Solutions, Inc. |
LABELER NAME: | Dispensing Solutions, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100([iU]/mL) |
START MARKETING DATE: | 2003-01-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68258-8899_5d8213bc-800b-4e52-af9e-3ba3e5f2650c |
PRODUCT NDC: | 68258-8899 |
APPLICATION NUMBER: | NDA020986 |
Other INSULIN ASPART Pharmaceutical Manufacturers / Labelers: